Trial Profile
A study evaluating the sensitivity and accuracy of 68Ga-DOTATATE PET-CT over 111In-octreotide SPECT-CT and conventional imaging for detecting lesions in medullary thyroid carcinoma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Mar 2018
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary) ; Indium-111-octreotide
- Indications Adenocarcinoma; Carcinoma; Thyroid cancer
- Focus Diagnostic use
- 27 Mar 2018 New trial record